- RANK-Fc: a therapeutic antagonist for RANK-L in myeloma. Cancer. 2003 Information Resource GET IT
- Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 2001 Academic Article GET IT
Chlorozotocin (DCNU)--induced pulmonary toxicity.
Cancer clinical trials.
Times cited: 4